TRAVERE THERAPEUTICS, INC. (TVTX) /
The profitability of TRAVERE THERAPEUTICS, INC. over the past 10 years
Chart TRAVERE THERAPEUTICS, INC.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →TRAVERE THERAPEUTICS, INC. reported a net loss of $25.55M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $480.39M and an operating loss of $62.82M. It reported a loss in all 10 years shown.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $480.39M* | -$62.82M | -$25.55M |
| 2024ended Dec 31, 2024 | $225.43M* | -$323.83M | -$321.55M |
| 2023ended Dec 31, 2023 | $133.79M* | -$388.14M | -$111.4M |
| 2022ended Dec 31, 2022 | $105.04M* | -$319.81M | -$278.48M |
| 2021ended Dec 31, 2021 | $128.02M* | -$199.43M | -$180.09M |
| 2020ended Dec 31, 2020 | $192.19M* | -$176.16M | -$169.43M |
| 2019ended Dec 31, 2019 | $170.1M* | -$137.36M | -$146.43M |
| 2018ended Dec 31, 2018 | $158.72M* | -$80.04M | -$102.68M |
| 2017ended Dec 31, 2017 | $151.33M* | -$53.79M | -$59.73M |
| 2016ended Dec 31, 2016 | $129.04M* | -$58.21M | -$47.9M |
Fiscal years as TRAVERE THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on TRAVERE THERAPEUTICS, INC.
- The revenue of TRAVERE THERAPEUTICS, INC.
- The cash flow of TRAVERE THERAPEUTICS, INC.
- The debt of TRAVERE THERAPEUTICS, INC.
- All of TRAVERE THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
Not investment advice. This page shows what TRAVERE THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.